«

»

Searching for Savings in Medicare Drug Price Negotiations

In response to higher drug spending growth and heightened attention to drug prices, some policymakers have proposed allowing Medicare to negotiate the price of prescription drugs. This issue brief provides a short history of this proposal, describes various approaches, and assessments of their potential savings from the Congressional Budget Office (CBO), and considers the prospects for action in the future.

Read the full post at Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive